Artificial Intelligence for Drug Discovery
Atomwise is the creator of AtomNet, the first Deep Learning technology for novel small molecule discovery, characterized by its unprecedented speed, accuracy, and diversity.
Research groups that partner with Atomwise gain powerful advantages in the scope, scale, and success rates of their drug discovery programs.